FY2026 EPS Estimates for Senseonics Boosted by HC Wainwright

Senseonics Holdings, Inc. (NYSE:SENS) – Stock analysts at HC Wainwright increased their FY2026 EPS estimates for Senseonics in a note issued to investors on Tuesday, July 8th. HC Wainwright analyst S. Lee now forecasts that the company will post earnings per share of ($0.05) for the year, up from their previous estimate of ($0.06). HC Wainwright has a “Buy” rating and a $1.40 price target on the stock. The consensus estimate for Senseonics’ current full-year earnings is ($0.14) per share.

A number of other equities analysts have also recently weighed in on SENS. Mizuho started coverage on shares of Senseonics in a research report on Thursday, April 10th. They set an “outperform” rating and a $2.00 price objective for the company. Wall Street Zen raised shares of Senseonics to a “sell” rating in a research note on Monday, May 12th.

Senseonics Price Performance

NYSE:SENS opened at $0.50 on Thursday. The stock has a market capitalization of $327.11 million, a PE ratio of -3.85 and a beta of 0.92. Senseonics has a 52 week low of $0.25 and a 52 week high of $1.40. The stock’s 50-day moving average price is $0.54 and its 200-day moving average price is $0.68. The company has a quick ratio of 2.38, a current ratio of 2.47 and a debt-to-equity ratio of 59.17.

Institutional Investors Weigh In On Senseonics

Large investors have recently added to or reduced their stakes in the business. First Light Asset Management LLC acquired a new stake in shares of Senseonics in the fourth quarter valued at $3,366,000. Geode Capital Management LLC boosted its stake in shares of Senseonics by 9.7% in the 4th quarter. Geode Capital Management LLC now owns 6,405,100 shares of the company’s stock valued at $3,354,000 after buying an additional 566,704 shares during the period. Jane Street Group LLC boosted its stake in shares of Senseonics by 6,694.1% in the 4th quarter. Jane Street Group LLC now owns 6,118,786 shares of the company’s stock valued at $3,203,000 after buying an additional 6,028,726 shares during the period. Charles Schwab Investment Management Inc. grew its holdings in Senseonics by 4.9% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 3,502,326 shares of the company’s stock worth $2,298,000 after acquiring an additional 162,628 shares in the last quarter. Finally, Renaissance Technologies LLC acquired a new position in Senseonics during the 4th quarter worth approximately $720,000. 12.36% of the stock is owned by hedge funds and other institutional investors.

About Senseonics

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.